vs

Side-by-side financial comparison of PURE CYCLE CORP (PCYO) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

PURE CYCLE CORP is the larger business by last-quarter revenue ($9.1M vs $4.9M, roughly 1.8× Sensus Healthcare, Inc.). PURE CYCLE CORP runs the higher net margin — 50.0% vs -64.1%, a 114.1% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs -62.2%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs -31.9%).

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

PCYO vs SRTS — Head-to-Head

Bigger by revenue
PCYO
PCYO
1.8× larger
PCYO
$9.1M
$4.9M
SRTS
Growing faster (revenue YoY)
PCYO
PCYO
+121.0% gap
PCYO
58.8%
-62.2%
SRTS
Higher net margin
PCYO
PCYO
114.1% more per $
PCYO
50.0%
-64.1%
SRTS
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
-31.9%
SRTS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PCYO
PCYO
SRTS
SRTS
Revenue
$9.1M
$4.9M
Net Profit
$4.6M
$-3.2M
Gross Margin
68.4%
38.4%
Operating Margin
48.0%
-63.8%
Net Margin
50.0%
-64.1%
Revenue YoY
58.8%
-62.2%
Net Profit YoY
16.0%
-304.9%
EPS (diluted)
$0.19
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCYO
PCYO
SRTS
SRTS
Q4 25
$9.1M
$4.9M
Q3 25
$11.2M
$6.9M
Q2 25
$5.1M
$7.3M
Q1 25
$4.0M
$8.3M
Q4 24
$5.8M
$13.1M
Q3 24
$12.6M
$8.8M
Q2 24
$7.6M
$9.2M
Q1 24
$3.2M
$10.7M
Net Profit
PCYO
PCYO
SRTS
SRTS
Q4 25
$4.6M
$-3.2M
Q3 25
$6.1M
$-943.0K
Q2 25
$2.3M
$-1.0M
Q1 25
$809.0K
$-2.6M
Q4 24
$3.9M
$1.5M
Q3 24
$6.6M
$1.2M
Q2 24
$2.8M
$1.6M
Q1 24
$118.0K
$2.3M
Gross Margin
PCYO
PCYO
SRTS
SRTS
Q4 25
68.4%
38.4%
Q3 25
67.7%
39.4%
Q2 25
63.4%
39.7%
Q1 25
38.2%
52.2%
Q4 24
63.8%
54.4%
Q3 24
77.8%
59.3%
Q2 24
64.0%
58.7%
Q1 24
55.6%
62.5%
Operating Margin
PCYO
PCYO
SRTS
SRTS
Q4 25
48.0%
-63.8%
Q3 25
53.1%
-37.3%
Q2 25
26.0%
-26.6%
Q1 25
-33.2%
-31.7%
Q4 24
29.9%
13.2%
Q3 24
62.0%
16.9%
Q2 24
40.3%
21.5%
Q1 24
-11.5%
27.1%
Net Margin
PCYO
PCYO
SRTS
SRTS
Q4 25
50.0%
-64.1%
Q3 25
54.5%
-13.7%
Q2 25
43.9%
-14.2%
Q1 25
20.3%
-30.8%
Q4 24
68.4%
11.8%
Q3 24
52.6%
13.7%
Q2 24
37.2%
17.4%
Q1 24
3.7%
21.3%
EPS (diluted)
PCYO
PCYO
SRTS
SRTS
Q4 25
$0.19
$-0.19
Q3 25
$0.26
$-0.06
Q2 25
$0.09
$-0.06
Q1 25
$0.03
$-0.16
Q4 24
$0.16
$0.10
Q3 24
$0.27
$0.07
Q2 24
$0.12
$0.10
Q1 24
$0.00
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCYO
PCYO
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$17.1M
$22.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$147.5M
$48.1M
Total Assets
$168.1M
$53.0M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCYO
PCYO
SRTS
SRTS
Q4 25
$17.1M
$22.1M
Q3 25
$21.9M
$24.5M
Q2 25
$14.4M
$22.2M
Q1 25
$16.5M
$19.1M
Q4 24
$19.0M
$22.1M
Q3 24
$22.1M
$22.6M
Q2 24
$20.5M
$19.0M
Q1 24
$20.6M
$14.7M
Total Debt
PCYO
PCYO
SRTS
SRTS
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
PCYO
PCYO
SRTS
SRTS
Q4 25
$147.5M
$48.1M
Q3 25
$142.7M
$51.2M
Q2 25
$136.7M
$52.1M
Q1 25
$134.4M
$53.0M
Q4 24
$133.6M
$55.8M
Q3 24
$129.7M
$54.1M
Q2 24
$123.2M
$52.9M
Q1 24
$120.4M
$51.2M
Total Assets
PCYO
PCYO
SRTS
SRTS
Q4 25
$168.1M
$53.0M
Q3 25
$162.3M
$58.3M
Q2 25
$151.7M
$58.9M
Q1 25
$149.7M
$60.2M
Q4 24
$149.7M
$62.2M
Q3 24
$147.4M
$59.9M
Q2 24
$140.4M
$58.2M
Q1 24
$135.2M
$57.3M
Debt / Equity
PCYO
PCYO
SRTS
SRTS
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCYO
PCYO
SRTS
SRTS
Operating Cash FlowLast quarter
$-979.0K
$-2.2M
Free Cash FlowOCF − Capex
$-2.4M
FCF MarginFCF / Revenue
-47.9%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCYO
PCYO
SRTS
SRTS
Q4 25
$-979.0K
$-2.2M
Q3 25
$9.4M
$2.3M
Q2 25
$-503.0K
$3.1M
Q1 25
$-1.4M
$-2.7M
Q4 24
$5.7M
$-827.0K
Q3 24
$3.1M
$4.0M
Q2 24
$892.0K
$4.2M
Q1 24
$-457.0K
$-8.2M
Free Cash Flow
PCYO
PCYO
SRTS
SRTS
Q4 25
$-2.4M
Q3 25
$2.3M
Q2 25
$3.1M
Q1 25
$-2.7M
Q4 24
$-1.1M
Q3 24
$3.6M
Q2 24
$4.2M
Q1 24
$-8.4M
FCF Margin
PCYO
PCYO
SRTS
SRTS
Q4 25
-47.9%
Q3 25
33.3%
Q2 25
42.2%
Q1 25
-32.2%
Q4 24
-8.6%
Q3 24
40.9%
Q2 24
45.8%
Q1 24
-79.0%
Capex Intensity
PCYO
PCYO
SRTS
SRTS
Q4 25
3.2%
Q3 25
0.1%
Q2 25
0.4%
Q1 25
0.1%
Q4 24
2.3%
Q3 24
3.8%
Q2 24
0.0%
Q1 24
2.2%
Cash Conversion
PCYO
PCYO
SRTS
SRTS
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
-0.53×
Q3 24
0.47×
3.25×
Q2 24
0.32×
2.62×
Q1 24
-3.87×
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons